🇺🇸 FDA
Patent

US 11839659

Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of indoleamine 2,3-dioxygenase (IDO) protein

granted A61KA61K47/545A61K47/55

Quick answer

US patent 11839659 (Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of indoleamine 2,3-dioxygenase (IDO) protein) held by Northwestern University expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Dec 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K47/545, A61K47/55, A61K47/64